Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.

A bioanalytical method for the analysis of oseltamivir (OP) and its metabolite oseltamivir carboxylate (OC) in human plasma, saliva and urine using off-line solid-phase extraction and liquid chromatography coupled to positive tandem mass spectroscopy has been developed and validated. OP and OC were...

Bibliografske podrobnosti
Main Authors:	Lindegårdh, N, Hanpithakpong, W, Wattanagoon, Y, Singhasivanon, P, White, N, Day, N
Format:	Journal article
Jezik:	English
Izdano:	2007

Podobne knjige/članki

A liquid chromatographic-tandem mass spectrometric method for determination of artemether and its metabolite dihydroartemisinin in human plasma.
od: Hanpithakpong, W, et al.
Izdano: (2009)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and Non-obese volunteers.
od: Chairat, K, et al.
Izdano: (2016)

A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma.
od: Hanpithakpong, W, et al.
Izdano: (2008)

Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers.
od: Instiaty, I, et al.
Izdano: (2013)

Pharmacokinetics of high-dose oseltamivir in healthy volunteers.
od: Wattanagoon, Y, et al.
Izdano: (2009)

Importance of collection tube during clinical studies of oseltamivir.
od: Lindegardh, N, et al.
Izdano: (2007)

Rapid degradation of oseltamivir phosphate in clinical samples by plasma esterases.
od: Lindegardh, N, et al.
Izdano: (2006)

Determination of Oseltamivir Quality by Colorimetric and Liquid Chromatographic Methods
od: Michael D. Green, et al.
Izdano: (2008-04-01)

Validation and application of a liquid chromatographic-mass spectrometric method for determination of artesunate in pharmaceutical samples.
od: Lindegårdh, N, et al.
Izdano: (2007)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects.
od: Jittamala, P, et al.
Izdano: (2014)

Chemical analysis and transplacental transfer of oseltamivir and oseltamivir carboxylic acid in pregnant rats.
od: Chia-Chun Lin, et al.
Izdano: (2012-01-01)

Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects
od: Jittamala, P, et al.
Izdano: (2014)

Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
od: Enno D Wildschut, et al.
Izdano: (2010-01-01)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy Thai adults.
od: Pukrittayakamee, S, et al.
Izdano: (2011)

An open-label crossover study to evaluate potential pharmacokinetic interactions between oral oseltamivir and intravenous zanamivir in healthy thai adults
od: Pukrittayakamee, S, et al.
Izdano: (2011)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
od: Lindegardh, N, et al.
Izdano: (2008)

A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
od: Guanghua Gao, et al.
Izdano: (2019-02-01)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
od: Jang K, et al.
Izdano: (2017-03-01)

Ode to Oseltamivir and Amantadine?
od: JM Conly, et al.
Izdano: (2006-01-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
od: Parvaiz A Koul, et al.
Izdano: (2024-01-01)

Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs’ excretion into the bile and kidney
od: Kunio Fujiwara, et al.
Izdano: (2020-06-01)

A simple and rapid liquid chromatographic assay for evaluation of potentially counterfeit Tamiflu.
od: Lindegårdh, N, et al.
Izdano: (2006)

Impact of Oseltamivir and Diabetes Development
od: Bor-Show Tzang, et al.
Izdano: (2025-01-01)

Impact of oseltamivir on the risk of cancer
od: Pei-Hua Chuang, et al.
Izdano: (2024-02-01)

Rapid Emergence of Oseltamivir Resistance
od: Cheng Len Sy, et al.
Izdano: (2010-04-01)

Assay to Detect Oseltamivir Resistance
od: Kamol Suwannakarn, et al.
Izdano: (2006-12-01)

Oseltamivir in pregnancy and birth outcomes
od: Vera Ehrenstein, et al.
Izdano: (2018-10-01)

Development and validation of a high-throughput zwitterionic hydrophilic interaction liquid chromatography solid-phase extraction-liquid chromatography-tandem mass spectrometry method for determination of the anti-influenza drug peramivir in plasma.
od: Lindegardh, N, et al.
Izdano: (2008)

Liquid chromatographic-mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria.
od: Sriboonvorakul, N, et al.
Izdano: (2013)

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
od: Tarning, J, et al.
Izdano: (2006)

Strategies for the Use of Oseltamivir and Zanamivir during Pandemic Outbreaks
od: Elsa Hansen, et al.
Izdano: (2010-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
od: A.B. Ivanyuk, et al.
Izdano: (2008-01-01)

OSELTAMIVIR MEDICATION IN THE PEDIATRIC PRACTICE: THE REVIEW
od: A.B. Ivanyuk, et al.
Izdano: (2008-01-01)

Oseltamivir and G6PD deficiency
od: Şinasi Özsoylu
Izdano: (2010-06-01)

Oseltamivir and G6PD deficiency
od: Şinasi Özsoylu
Izdano: (2010-06-01)

Oseltamivir Enhances Hippocampal Network Synchronization
od: Atsushi Usami, et al.
Izdano: (2008-01-01)

Oseltamivir for the treatment of influenza in children and adolescents
od: Alfredo Tagarro, et al.
Izdano: (2019-05-01)

Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics.
od: Seo, S, et al.
Izdano: (2013)

Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection
od: Wang, Y, et al.
Izdano: (2019)

Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
od: Taylor, W, et al.
Izdano: (2008)